B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
Abstract Although most differentiated thyroid carcinoma has a clinically favorable prognosis, some of specific types of thyroid cancer (such as anaplastic thyroid carcinoma and advanced papillary thyroid carcinoma) show fatal outcomes and require novel treatments. Immunotherapy is a promising avenue...
Saved in:
Main Authors: | Pengtao Song (Author), Yongcan Xu (Author), Guochao Ye (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
by: Xiaoyan Qin, et al.
Published: (2021) -
Outcomes and Therapeutic Management of Thyroid Carcinoma
Published: (2023) -
Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis
by: Xiaoyan Qin, et al.
Published: (2023) -
Tuning Design Parameters of ICAM-1-Targeted 3DNA Nanocarriers to Optimize Pulmonary Targeting Depending on Drug Type
by: Nikša Roki, et al.
Published: (2022) -
Role of TRPM7 in Cancer: Potential as Molecular Biomarker and Therapeutic Target
by: Nelson S. Yee
Published: (2017)